Effects of indomethacin on the production of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinases-1 by human articular chondrocytes

Journal of Rheumatology

Volumn 23, Issue 10, 1996, Pages 1739-1743

  Yamada, Harumoto ^a   Kikuchi, Toshiyuki ^a   Nemoto, Osamu ^a   Obata, Ken'ichi ^b   Sato, Hiroshi ^c   Seiki, Motoharu ^c   Shinmei, Masayuki ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b FUJI CHEMICAL INDUSTRIES LTD   (Japan)

^c KANAZAWA UNIVERSITY   (Japan)

Author keywords

cartilage; chondrocyte; matrix metalloproteinases; nonsteroidal antiinflammatory drugs; osteoarthritis; tissue inhibitor of metalloproteinases

Indexed keywords

INDOMETACIN; METALLOPROTEINASE INHIBITOR; PROSTAGLANDIN E2; RECOMBINANT INTERLEUKIN 1BETA; STROMELYSIN;

ARTICLE; ARTICULAR CARTILAGE; CARTILAGE CELL; CONTROLLED STUDY; ENZYME SYNTHESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL;

BLOTTING, NORTHERN; CARTILAGE, ARTICULAR; CELLS, CULTURED; COLLAGENASES; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; GLYCOPROTEINS; HUMANS; INDOMETHACIN; INTERLEUKIN-1; MATRIX METALLOPROTEINASE 3; PROTEASE INHIBITORS; RNA, MESSENGER; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 0029801511     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Barrett AJ: The enzymic degradation of cartilage matrix. In: Burleigh PMC, Poole AR, eds. Dynamics of Connective Tissue Macromolecules. Amsterdam: North-Holland, 1975:189-226.
2. Nagase H, Woessner JF: Role of endogenous proteinases in the degradation of cartilage matrix. In: Woessner JF, Howell DS, eds. Joint Cartilage Degradation. New York: Marcel Dekker, 1993:159-85.
3. Sapolsky AI, Keiser H, Howell DS, Woessner JF: Metalloproteinases of human articular cartilage that digest cartilage proteoglycan at neutral and acid pH. J Clin Invest 1976;58:1030-41.
4. Martel-Pelletier J, Pelletier JP, Cloutier JM, Howell DS, Ghandur-Mnaymneh L, Woessner JF: Neutral proteases capable of proteoglycan digesting activity in osteoarthritic and normal human articular cartilage. Arthritis Rheum 1984;27:305-12.
5. Werb Z: The biologic role of metalloproteinases and their inhibitors. In: Kuettner KE, ed. Articular Cartilage and Osteoarthritis. New York: Raven Press, 1992:295-304.
6. Mehraban F, Kuo SY, Riera H, Chang C, Moskowitz RW: Prostromelysin and procollagenase genes are differentially up-regulated in chondrocytes from the knees of rabbits with experimental osteoarthritis. Arthritis Rheum 1994;37:1189-97.
7. Nguyen Q, Murphy G, Roughley PJ, Mort JS: Degradation of proteoglycan aggregate by a cartilage metalloproteinase. Evidence for the involvement of stromelysin in the generation of link protein heterogeneity in situ. Biochem J 1989;259:61-7.
8. Okada Y, Shinmei M, Tanaka O, et al.: Localization of matrix metalloproteinase 3 (stromelysin) in osteoarthritic cartilage and synovium. Lab Invest 1992;66:680-90.
9. Cawston TE, Mercer E, de Silva M, Hazleman BL: Metalloproteinases and collagenase inhibitors in rheumatoid synovial fluid. Arthritis Rheum 1984;27:285-90.
10. Otsuka K, Sodek J, Limeback H: Synthesis of collagenase and collagenase inhibitors by osteoblast-like cells in culture. Eur J Biochem 1984;145:123-9.
11. Morales TI, Kuettner KE, Howell DS, Woessner JF: Characterization of the metalloproteinase inhibitor produced by bovine articular chondrocyte cultures. Biochim Biophys Acta 1983;760:221-9.
12. Vignon E, Mathieu P, Louis P, Richard M: In vitro effect of nonsteroidal antiinflammatory drug on proteoglycanase and collagenase activity in human osteoarthritic cartilage. Arthritis Rheum 1991;34:1332-5.
13. Pelletier JP, Martel-Pelletier J: In vivo protective effects of prophylactic treatment with tiaprofenic acid or intraarticular corticosteroids on osteoarthritic lesions in the experimental dog model J Rheumatol 1991;(suppl 27)18:127-30.
14. Shinmei M, Kikuchi T, Masuda K, Shimomura Y: Effects of interleukin-1 and anti-inflammatory drugs on the degradation of human articular cartilage. Drugs 1988;(suppl 1)35:33-41.
15. Pelletier JP, Cloutier JM, Martel-Pelletier J: In vitro effects of tiaprofenic acid, sodium salicylate and hydrocortisone on the proteoglycan metabolism of human osteoarthritic cartilage. J Rheumatol 1989;16:646-55.
16. Lane NE, Williams RJ, Schurman DJ, Smith RL: Inhibition of interleukin 1 induced chondrocyte protease activity by a corticosteroid and a nonsteroidal antiinflammatory drug. J Rheumatol 1992;19:135-9.
17. Obata K, Iwata K, Okada Y, et al.: A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 3 (stromelysin-1) using monoclonal antibodies, Clin Chim Acta 1992;211:59-72.
18. Kodama S, Iwata K, Iwata H, Yamashita K, Hayakawa T: Rapid one-step sandwich enzyme immunoassay for tissue inhibitor of metalloproteinases. An application for rheumatoid arthritis serum and plasma. J Immunol Methods 1990;127:103-8.
19. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
20. Sambrook J, Fritsch EF, Maniatis T: Analysis of RNA. In: Molecular Cloning. New York: Cold Spring Harbor Laboratory Press, 1989:7.37-7.50.
21. Sato H, Kida Y, Mai M, et al.: Expression of genes encoding type IV collagen-degrading metalloproteinases and tissue inhibitors of metalloproteinases in various human tumor cells. Oncogene 1992;7:77-83.
22. Rashad S, Revell P, Hemingway A, Low F, Rainsford K, Walker F: Effect of non-steroidal anti-inflammatory drugs on the course of osteoarthritis. Lancet 1989;2:519-22.
23. Brandt KD: Effects of nonsteroidal anti-inflammatory drugs on chondrocyte metabolism in vitro and in vivo. Am J Med 1987; (suppl 5A)83:29-34.
24. Mitrovic D, McCall E, Front Ph, Aprile F, Darmon N, Dray F: Anti-inflammatory drugs, prostanoid and proteoglycan production by cultured bovine articular chondrocytes. Prostaglandins 1984;28:417-34.
25. Palmoski MJ, Brandt KD: Relationship between matrix proteoglycan content and the effects of salicylate and indomethacin on articular cartilage. Arthritis Rheum 1983;26:528-31.
26. Mckenzie LS, Horsburgh BA, Ghosh P, Taylor TKF: Effect of anti-inflammatory drugs on sulphated glycosaminoglycan synthesis in aged human articular cartilage. Ann Rheum Dis 1976;35:487-97.
27. Fujii K, Tajiri K, Kajiwara T, Tanaka T, Murota K: Effects of NSAID on collagen and proteoglycan synthesis of cultured chondrocytes. J Rheumatol 1989;(suppl 18)16:28-31.
28. Shinmei M, Inamori Y, Yoshihara Y, Kikuchi T, Shimomura Y: The potentials of cartilage markers in joint fluid for drug evaluation. In: Kuettner KE, ed. Articular Cartilage and Osteoarthritis. New York: Raven Press, 1992:597-609.
29. Lohmander LS, Hoerrner LA, Lark MW: Metalloproteinases, tissue inhibitor, and proteoglycan fragments in knee synovial fluid in human osteoarthritis. Arthritis Rheum 1993;36:181-9.
30. Lefebvre V, Peeters-Joris C, Vaes G: Modulation by interleukin 1 and tumor necrosis factor α of production of collagenase, tissue inhibitor of metalloproteinases and collagen types in differentiated and dedifferentiated articular chondrocytes. Biochem Biophys Acta 1990;1052:366-78.